Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290237 · ClinicalTrials.gov registry record · NA
Use of a Loading Dose of Vancomycin in Pediatric Dosing
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01290237 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 59 participants.
The verdict
NCT01290237, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
Vancomycin is an antibiotic administered to children or adults for many types of infections. While it has been used to treat infections of children for more than 50 years we are still not completely certain about the best dose to use when starting treatment with this medication. This study is intended to evaluate whether giving a new higher dose of vancomycin for the first dose will help us get to the desired amount in the body more quickly then the usual first dose. Half of the patients would get the new higher dose and the other half of patients will get the typical first dose. Only the first dose is changed and all doses that follow are the same in both groups and are doses typically used for children.
Interventions
- DRUG vancomycin hydrocloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01290237
The ClinicalTrials.gov registry entry for NCT01290237 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vancomycin hydrocloride is the first listed.
NCT01290237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01290237 about?
NCT01290237 is a clinical study titled "Use of a Loading Dose of Vancomycin in Pediatric Dosing". Vancomycin is an antibiotic administered to children or adults for many types of infections. While it has been used to treat infections of children for more than 50 years we are still not completely certain about the best dose to use when starting treatment with this medication. This study is inten...
What is the current status of trial NCT01290237?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2011-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01290237?
The interventions under investigation include: vancomycin hydrocloride (DRUG).
Who is sponsoring clinical trial NCT01290237?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.